Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
14%(1 trials)

Phase Distribution

Ph phase_3
3
33%
Ph not_applicable
1
11%
Ph phase_4
2
22%
Ph phase_2
3
33%

Phase Distribution

0

Early Stage

3

Mid Stage

5

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
3(33.3%)
Phase 3Large-scale testing
3(33.3%)
Phase 4Post-market surveillance
2(22.2%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(7)
Other(2)

Detailed Status

Completed7
unknown2

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (33.3%)
Phase 33 (33.3%)
Phase 42 (22.2%)
N/A1 (11.1%)

Trials by Status

unknown222%
completed778%

Recent Activity

0 active trials
Showing 5 of 9
completedphase_2

Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in HIV

NCT00084149
completedphase_3

Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV

NCT00086359
completedphase_2

Increasing HAART-Induced Immune Restoration With Cyclosporine

NCT00031070
completednot_applicable

Blood Levels of Abacavir in HIV Infected Adolescents

NCT00087945
completedphase_3

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

NCT00013520
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT00084149Phase 2

Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in HIV

Completed
NCT00086359Phase 3

Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV

Completed
NCT00031070Phase 2

Increasing HAART-Induced Immune Restoration With Cyclosporine

Completed
NCT00087945Not Applicable

Blood Levels of Abacavir in HIV Infected Adolescents

Completed
NCT00013520Phase 3

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

Completed
NCT00021463Phase 2

Changing to Nonprotease Inhibitor Treatment to Improve Side Effects

Completed
NCT00004585Phase 4

A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults

Completed
NCT00011895Phase 4

Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Unknown
NCT00004981Phase 3

Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)

Unknown

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9